ELVElevance Health
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.3 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +9% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 2.7% now against 4.0% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ELV growing?
Elevance Health has grown revenue 6.7% a year over three years and 9.3% a year over five, with earnings per share compounding at −5.0%.
Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +9.3%
Revenue growth, 5-year rate · +6.7% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −5.0%
Earnings per share, 3-year rate · revenue +6.7% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $138.6B
- Revenue FY2022
- $156.6B
- Revenue FY2023
- $171.3B
- Revenue FY2024
- $177.0B
- Revenue FY2025
- $199.1B
Annual income statements as filed with the SEC.
Healthcare
Ranks #17 of 446 by RyuScore